What is the most likely diagnosis in a 65-year-old woman presenting with progressive fatigue, supraclavicular lymphadenopathy, a markedly elevated white‑blood‑cell count predominantly lymphocytic, and peripheral smear showing small mature lymphocytes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Chronic Lymphocytic Leukemia (CLL)

The most likely diagnosis is Chronic Lymphocytic Leukemia (CLL), based on the combination of marked lymphocytosis (53,800/mm³ with 84% lymphocytes), small mature lymphocytes on peripheral smear, supraclavicular lymphadenopathy, and the patient's age of 65 years.

Clinical Reasoning

This patient presents with the classic triad of CLL:

  • Marked absolute lymphocytosis: WBC 53,800/mm³ with 84% lymphocytes (approximately 45,192 lymphocytes/mm³), far exceeding the diagnostic threshold
  • Peripheral smear findings: Small, mature-appearing lymphocytes—the hallmark cytomorphologic feature of CLL
  • Lymphadenopathy: Large, firm, mobile supraclavicular nodes indicating lymphoid tissue involvement

The 2-month history of progressive fatigue without B-symptoms (no fevers, night sweats, or weight loss) and preserved hemoglobin (12 g/dL) and platelets (224,000/mm³) suggests early to intermediate-stage disease without significant marrow failure 1.

Diagnostic Confirmation Required

Before finalizing management, the following must be obtained:

  • Flow cytometry to confirm clonal B-cell population with characteristic CLL immunophenotype (CD5+, CD19+, CD23+, dim CD20, dim surface immunoglobulin)
  • FISH testing for del(17p) and TP53 mutation status—critical for risk stratification 1, 2
  • IGHV mutation status—determines prognosis and influences treatment selection 1, 2

Staging and Management Approach

Based on the clinical presentation with supraclavicular lymphadenopathy and no cytopenias, this patient likely has Rai Stage I-II (intermediate risk) or Binet Stage B disease 1.

Watch-and-Wait Strategy

This patient does NOT require immediate treatment and should be managed with observation 1. The ESMO guidelines explicitly state that early treatment with chemotherapeutic agents does not translate into survival advantage in early-stage CLL, making watch-and-wait the standard approach 1.

The patient should be monitored with:

  • Blood counts and clinical examinations every 3-12 months 1
  • More frequent monitoring (every 3 months) during the first year 1

Treatment Indications to Monitor For

Treatment should be initiated only when "active disease" criteria are met 1:

  1. Progressive marrow failure: Hemoglobin <100 g/L or platelets <100×10⁹/L
  2. Massive lymphadenopathy: Nodes ≥10 cm in longest diameter, or progressive/symptomatic nodes
  3. Massive splenomegaly: ≥6 cm below left costal margin, or progressive/symptomatic
  4. Progressive lymphocytosis: 50% increase over 2 months or lymphocyte doubling time <6 months
  5. Constitutional symptoms: Severe fatigue, unintentional weight loss >10% in 6 months, fevers >38°C for ≥2 weeks, or drenching night sweats
  6. Autoimmune cytopenias poorly responsive to corticosteroids
  7. Symptomatic extranodal involvement

Critical Pitfalls to Avoid

  • Do not treat based on lymphocyte count alone—absolute lymphocytosis is NOT an indication for treatment 2
  • Leukostasis is exceedingly rare in CLL despite high WBC counts 2, unlike acute leukemias
  • Avoid serial CT scans in asymptomatic patients—clinical examination and blood counts suffice 2
  • Rule out other causes of fatigue (infections, sleep disorders, thyroid dysfunction) before attributing symptoms solely to CLL 1
  • Obtain prognostic markers before any future treatment decision, not just at diagnosis 2

Differential Considerations

While CLL is overwhelmingly likely, the differential for lymphocytosis with mature lymphocytes includes:

  • Monoclonal B-cell lymphocytosis (MBL): Excluded by the markedly elevated lymphocyte count (>5×10⁹/L threshold) 3
  • Small lymphocytic lymphoma (SLL): Tissue-based diagnosis with minimal peripheral involvement—not consistent with this presentation
  • Reactive lymphocytosis: Would not produce this degree of sustained lymphocytosis with lymphadenopathy

The supraclavicular location of lymphadenopathy warrants attention, as these nodes have higher malignancy rates 4, 5, but the peripheral blood findings definitively point to CLL rather than solid tumor metastases.

References

4
Research

Diagnostic evaluation of supraclavicular lymphadenopathy.

Mymensingh medical journal : MMJ, 2013

5
Research

Lymphadenopathy: Evaluation and Differential Diagnosis.

American family physician, 2025

Related Questions

What is the most likely diagnosis in a 23-year-old male with tender bilateral cervical lymphadenopathy, tonsillitis-like symptoms, lymphocyte-predominant leukocytosis (~17,000), splenomegaly, and mild transaminitis?
In a 26-year-old active‑duty male with no significant past medical history who presents with a tender, warm, erythematous right inguinal lymphadenopathy larger than 1 cm with a central brown spot, no fever, no recent travel or antibiotic use, and a history of allergic rhinitis, post‑nasal drip, and a sub‑acute cough treated with albuterol inhaler, what is the appropriate diagnostic work‑up and initial management?
In a 20-year-old college student presenting with sore throat, fever, generalized lymphadenopathy, tonsillar exudates, splenomegaly, and atypical lymphocytes on peripheral smear, what is the most appropriate diagnostic test?
In a 32‑year‑old man with a history of marijuana use who presents with right‑leg tingling, leukocytosis (white blood cell count 12.7 ×10⁹/L) with absolute neutrophil count 10,668/µL, albumin 5.2 g/dL, and normal erythrocyte sedimentation rate and C‑reactive protein, what is the appropriate initial diagnostic work‑up and management?
What is the appropriate evaluation and management for a 12-year-old boy presenting with bilateral inguinal lymphadenopathy?
What is the recommended acute and secondary‑prevention management for a posterior‑inferior myocardial infarction?
I am feeling severe cramp-like (muscle spasm) pain during bladder irrigation via catheter; what is causing this and how should I manage it?
Which statement about live (attenuated) vaccines is correct?
Should metronidazole be administered with a loading dose?
What is the recommended ceftriaxone dose for treating uncomplicated enteric fever in adults and children according to Indian guidelines?
What is the ICD-10-CM code for exercise-induced asthma?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.